Report error Found 89 Enz. Inhib. hit(s) with all data for entry = 13295
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 3nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info
TargetIsoform Truncated 1 of E3 ubiquitin-protein ligase CBL-B [36-427] (Human)
Orum Therapeutics
US Patent
Orum Therapeutics
US Patent
Affinity DataIC50: 12.5nMAssay Description:Compounds were assessed for binding activity to Cbl-b by their ability to compete with and displace a probe comprised of BODIPY-FL fluorophore conjug...More data for this Ligand-Target Pair
Ligand Info

















































